Jessica Ailani, MD, FAHS, @RebeccaCBurch, MD, FAHS, and @mrrobbinsmd, MD, FAHS, published a revised consensus statement on integrating new #migraine and #headache therapies into treatment. Read this article https://t.co/EFf8dMN54E ! @HeadacheJournal #Neurology #MedEd https://t.co/7MdBkCrow4
The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Jun 2021 – Oct 2025Where it's discussed
-
News78 articles
-
X / Twitter72 posts
-
YouTube5 videos
-
Facebook4 posts
-
Blogs2 articles
AI synopsis
What people are saying
The discussions highlight specific aspects of the consensus statement, such as patient-centered approaches and personalized treatment mentioning 'how can we ensure that patient preferences are adequately considered?' and 'we have so many acute treatments for migraine now that Dr. Ailani recommends using tables from the consensus statement.' The choice of words like 'controversy' and phrases emphasizing 'must consider' and 'bold and practical view' contribute to a tone that suggests both urgency and a desire for meaningful discourse about the application of these recommendations.
Many discussions reflect a positive reception of the updates, with participants acknowledging the relevance of the new treatments.
There is a strong curiosity reflected in the discussions, indicating that the topic is important and relevant to those affected by migraines.
While some users provided deeper reactions or questions regarding treatment integration, others remained more surface-level in their engagement.
Several posts highlight the potential for these updates to significantly influence clinical practice, suggesting a belief in their impactful nature.
Abstract in brief
- The American Headache Society updated its Consensus Statement to incorporate new research, expert opinions, and patient feedback regarding acute and preventive migraine treatments for adults.
- This update outlines key recommendations based on newly available data on treatments, including CGRP receptor antagonists and a variety of neuromodulation techniques.
- The update process involved reviewing recent treatment efficacy, gathering insights from board members and patients, and integrating findings into practical guidance for clinicians.
Top posts
Most liked on X and BlueskyFree Access: The @ahsheadache Consensus Statement: Update on integrating new #migraine treatments into clinical practice @RebeccaCBurch Jessica Ailani MD, @mrobbinsmd https://t.co/gOntXRmgom https://t.co/tPFmMMUQgt
AHS Consensus Statement on integrating new migraine treatments into clinical practice #migraine @HeadacheJournal @ahsheadache https://t.co/8Nwg0SJm2r
We have so many acute treatments for #migraine now that Dr. Ailani recommends using tables from the @ahsheadache consensus statement to stay organized in clinic https://t.co/xCtwUAkntr. #AHSAZ21
The American Headache Society Consensus Statement: update on integrating new migraine treatments into clinical practice https://t.co/6Fr5Ung05t
Read the @ahsheadache American Headache Society Consensus Statement: Update on Integrating New #Migraine Treatments into Clinical Practice. It's just published in @HeadacheJournal: https://t.co/hu80hbjU87 https://t.co/F1xcJIqqqk
All mentions
Non-Migraine-Specific Preventive Medications: Chapter 6, Video 4
Factors Contributing to Transition from Episodic to Chronic Migraine
About 23% of people with episodic migraine transition to chronic migraine each year. This video explores risk factors and prevention methods, providing insights based on the latest research and expert recommendations…
What You Need to Know About Acute & Preventive Migraine Treatments - Explainer Video Series
Enxaqueca no ambulatório - Episódio 171
Migraine vs. Headache: Recognition and Urgent Care Guidelines
Learn to recognize migraine symptoms and take action within the first 30 minutes to avoid overuse of painkillers. This video outlines warning signs, specific prevention strategies, and incorporates recent guidelines…
A recent update by the American Headache Society shows new personalized treatments which have caused quite the controversy. How can we ensure that patient preferences and traits are adequately considered in treatment planning? #HPEX353_1 #HRD @HPEX353_1 https://t.co/pgLTf4461v
#medicine #medicalsciences #health #migraine #headaches https://t.co/Sng6znpYLn
The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice Read NOW - https://t.co/HYql0w0eVf #docquity #medical #migraine #doctors #LatestUpdate https://t.co/kw5nmOFIXD
Otros medicamentos aprobados por la FDA
RT @neudrawlogy:
@Mousecat1980 https://t.co/n1TLU5MpQT
RT @chidambara09: https://t.co/0NgJ8QR5D6 #LAZiOdigitale #dataScientist #CLOUd #QUANTUm #DES2022 #CX #WOMEN #eHealth #CES2023 #finServ #in…
RT @chidambara09: https://t.co/0NgJ8QR5D6 #LAZiOdigitale #dataScientist #CLOUd #QUANTUm #DES2022 #CX #WOMEN #eHealth #CES2023 #finServ #in…
RT @chidambara09: https://t.co/0NgJ8QR5D6 #LAZiOdigitale #dataScientist #CLOUd #QUANTUm #DES2022 #CX #WOMEN #eHealth #CES2023 #finServ #in…
https://t.co/0NgJ8QR5D6 #LAZiOdigitale #dataScientist #CLOUd #QUANTUm #DES2022 #CX #WOMEN #eHealth #CES2023 #finServ #inSurTech #bigdata #100daysOfCode #javaScript #flutter #linux #rObOtiCs #TRAVELtech #USA #FRENCHtech #TeCh4gOod #Technology #SOciaLmediA @BetaMoroney @enilev
@MartinaZackova @zztvcka Tohle jste četla? Co si o tom myslíte? https://t.co/cdt52s8r2r https://t.co/Q6dtULqglX
PubMed: The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice https://t.co/RtGpK2BFsW
Declaración de consenso de la Sociedad Americana de Cefaleas: Actualización sobre la integración de nuevos tratamientos de migraña en la práctica clínica. https://t.co/dkuqe7z7ky
RT @melissarayhill: We have so many acute treatments for #migraine now that Dr. Ailani recommends using tables from the @ahsheadache consen…
RT @melissarayhill: We have so many acute treatments for #migraine now that Dr. Ailani recommends using tables from the @ahsheadache consen…
RT @melissarayhill: We have so many acute treatments for #migraine now that Dr. Ailani recommends using tables from the @ahsheadache consen…
RT @melissarayhill: We have so many acute treatments for #migraine now that Dr. Ailani recommends using tables from the @ahsheadache consen…
RT @melissarayhill: We have so many acute treatments for #migraine now that Dr. Ailani recommends using tables from the @ahsheadache consen…
RT @melissarayhill: We have so many acute treatments for #migraine now that Dr. Ailani recommends using tables from the @ahsheadache consen…
RT @melissarayhill: We have so many acute treatments for #migraine now that Dr. Ailani recommends using tables from the @ahsheadache consen…
RT @melissarayhill: We have so many acute treatments for #migraine now that Dr. Ailani recommends using tables from the @ahsheadache consen…
RT @melissarayhill: We have so many acute treatments for #migraine now that Dr. Ailani recommends using tables from the @ahsheadache consen…
RT @melissarayhill: We have so many acute treatments for #migraine now that Dr. Ailani recommends using tables from the @ahsheadache consen…
We have so many acute treatments for #migraine now that Dr. Ailani recommends using tables from the @ahsheadache consensus statement to stay organized in clinic https://t.co/xCtwUAkntr. #AHSAZ21
34) You start her on Candesartan for migraine prevention, her blood pressure is better, and frequency of migraine attacks decreased. https://t.co/luoTcusTgu
#ScienceSunday #MigraineMatters #CMAware #NotAlone https://t.co/4LdSewT5tf
The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice - Ailani - 2021 - Headache: The Journal of Head and Face Pain - Wiley Online Library https://t.co/dkuqe7z7ky
RT @migraine_ce: 24) The criteria for initiating treatment with monoclonal antibodies to calcitonin gene-related peptide or its receptor ar…
24) The criteria for initiating treatment with monoclonal antibodies to calcitonin gene-related peptide or its receptor are (Headache 2021 Jun 23. doi: 10.1111/head.14153): • Migraine with or without aura, 4–7 mean migraine days
RT @migraine_ce: 6) Special considerations when choosing migraine prevention are based on subtype (chronic migraine vs migraine) and the pr…
7) The choice of migraine prevention should also be based of evidenced of efficacy, potential side effects, comorbidities, circumstance such as pregnancy or breastfeeding, cost, and personal choice (Headache 2021 doi: 10.1111/head.14153).
6) Special considerations when choosing migraine prevention are based on subtype (chronic migraine vs migraine) and the presence of comorbidities such as anxiety, depression, obesity, insomnia, chronic pain, and medication overuse headache (Headache 2021 doi: 10.1111/head.14153)
RT @GastonFRodrigu1: Declaración de consenso de la Sociedad Americana del Dolor de Cabeza: Actualización sobre la integración de nuevos tra…
Declaración de consenso de la Sociedad Americana del Dolor de Cabeza: Actualización sobre la integración de nuevos tratamientos para la migraña en la práctica clínica - Ailani - - Dolor de cabeza: The Journal of Head and Face Pain - https://t.co/dkuqe7z7ky
RT @ahsheadache: Jessica Ailani, MD, FAHS, @RebeccaCBurch, MD, FAHS, and @mrrobbinsmd, MD, FAHS, published a revised consensus statement on…
RT @ahsheadache: Jessica Ailani, MD, FAHS, @RebeccaCBurch, MD, FAHS, and @mrrobbinsmd, MD, FAHS, published a revised consensus statement on…
RT @ahsheadache: Jessica Ailani, MD, FAHS, @RebeccaCBurch, MD, FAHS, and @mrrobbinsmd, MD, FAHS, published a revised consensus statement on…
Jessica Ailani, MD, FAHS, @RebeccaCBurch, MD, FAHS, and @mrrobbinsmd, MD, FAHS, published a revised consensus statement on integrating new #migraine and #headache therapies into treatment. Read this article https://t.co/EFf8dMN54E ! @HeadacheJournal #Neurology #MedEd https://t.co/7MdBkCrow4
RT @HeadacheJournal: Free Access: The @ahsheadache Consensus Statement: Update on integrating new #migraine treatments into clinical practi…
@ahsheadache Consensus Statement: Update on integrating new #migraine treatments into clinical practice - bold and practical view of the data and putting patient's first! #digtalhealth and #medtech have a clear role in reducing pain. https://t.co/TcEyX97X8y
RT @HeadacheJournal: Free Access: The @ahsheadache Consensus Statement: Update on integrating new #migraine treatments into clinical practi…
RT @aagelfand: AHS Consensus Statement on integrating new migraine treatments into clinical practice #migraine @HeadacheJournal @ahsheadach…
RT @HeadacheJournal: Free Access: The @ahsheadache Consensus Statement: Update on integrating new #migraine treatments into clinical practi…
RT @aagelfand: AHS Consensus Statement on integrating new migraine treatments into clinical practice #migraine @HeadacheJournal @ahsheadach…
RT @aagelfand: AHS Consensus Statement on integrating new migraine treatments into clinical practice #migraine @HeadacheJournal @ahsheadach…
RT @HeadacheJournal: Free Access: The @ahsheadache Consensus Statement: Update on integrating new #migraine treatments into clinical practi…
RT @HeadacheJournal: Free Access: The @ahsheadache Consensus Statement: Update on integrating new #migraine treatments into clinical practi…
RT @WileyHealth: Read the @ahsheadache American Headache Society Consensus Statement: Update on Integrating New #Migraine Treatments into C…
Read the @ahsheadache American Headache Society Consensus Statement: Update on Integrating New #Migraine Treatments into Clinical Practice. It's just published in @HeadacheJournal: https://t.co/hu80hbjU87 https://t.co/F1xcJIqqqk
RT @aagelfand: AHS Consensus Statement on integrating new migraine treatments into clinical practice #migraine @HeadacheJournal @ahsheadach…
RT @GastonFRodrigu1: Declaración de consenso de la Sociedad Americana del Dolor de Cabeza: Actualización sobre la integración de nuevos tra…
RT @HeadacheJournal: Free Access: The @ahsheadache Consensus Statement: Update on integrating new #migraine treatments into clinical practi…
RT @aagelfand: AHS Consensus Statement on integrating new migraine treatments into clinical practice #migraine @HeadacheJournal @ahsheadach…
RT @HeadacheJournal: Free Access: The @ahsheadache Consensus Statement: Update on integrating new #migraine treatments into clinical practi…
RT @aagelfand: AHS Consensus Statement on integrating new migraine treatments into clinical practice #migraine @HeadacheJournal @ahsheadach…
RT @GastonFRodrigu1: Declaración de consenso de la Sociedad Americana del Dolor de Cabeza: Actualización sobre la integración de nuevos tra…
RT @WileyNeuro: The American Headache Society Consensus Statement: Update on integrating new #migraine treatments into clinical practice. @…
RT @HeadacheJournal: Free Access: The @ahsheadache Consensus Statement: Update on integrating new #migraine treatments into clinical practi…
The American Headache Society Consensus Statement: Update on integrating new #migraine treatments into clinical practice. @ahsheadache Just published, read it now in @HeadacheJournal. >>> https://t.co/XQ6NmplDrs https://t.co/IQbD0bKrAv
Declaración de consenso de la Sociedad Americana del Dolor de Cabeza: Actualización sobre la integración de nuevos tratamientos para la migraña en la práctica clínica. https://t.co/eMjCZ5gNoh
RT @NatRevNeurol: The American Headache Society Consensus Statement: update on integrating new migraine treatments into clinical practice h…
Free Access: The @ahsheadache Consensus Statement: Update on integrating new #migraine treatments into clinical practice @RebeccaCBurch Jessica Ailani MD, @mrobbinsmd https://t.co/gOntXRmgom https://t.co/tPFmMMUQgt
The American Headache Society Consensus Statement: update on integrating new migraine treatments into clinical practice https://t.co/6Fr5Ung05t
RT @aagelfand: AHS Consensus Statement on integrating new migraine treatments into clinical practice #migraine @HeadacheJournal @ahsheadach…
The #AmericanHeadacheSociety consensus statement on #migraine treatment integrating newer medications #CGRPs #Gepants #Ditans https://t.co/ulcrJ0mz3t
RT @aagelfand: AHS Consensus Statement on integrating new migraine treatments into clinical practice #migraine @HeadacheJournal @ahsheadach…
RT @aagelfand: AHS Consensus Statement on integrating new migraine treatments into clinical practice #migraine @HeadacheJournal @ahsheadach…
RT @aagelfand: AHS Consensus Statement on integrating new migraine treatments into clinical practice #migraine @HeadacheJournal @ahsheadach…
RT @aagelfand: AHS Consensus Statement on integrating new migraine treatments into clinical practice #migraine @HeadacheJournal @ahsheadach…
RT @aagelfand: AHS Consensus Statement on integrating new migraine treatments into clinical practice #migraine @HeadacheJournal @ahsheadach…
AHS Consensus Statement on integrating new migraine treatments into clinical practice #migraine @HeadacheJournal @ahsheadache https://t.co/8Nwg0SJm2r